Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis.

Gómez AC, Rodríguez-Fernández P, Villar-Hernández R, Gibert I, Muriel-Moreno B, Lacoma A, Prat-Aymerich C, Domínguez J.

PLoS One. 2020 Feb 10;15(2):e0228919. doi: 10.1371/journal.pone.0228919. eCollection 2020.

2.

Cigarette smoke exposure redirects Staphylococcus aureus to a virulence profile associated with persistent infection.

Lacoma A, Edwards AM, Young BC, Domínguez J, Prat C, Laabei M.

Sci Rep. 2019 Jul 25;9(1):10798. doi: 10.1038/s41598-019-47258-6.

3.

Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections.

Lacoma A, Mateo L, Blanco I, Méndez MJ, Rodrigo C, Latorre I, Villar-Hernandez R, Domínguez J, Prat C.

Front Immunol. 2019 May 7;10:1013. doi: 10.3389/fimmu.2019.01013. eCollection 2019. Review.

4.

Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis.

Andreu V, Larrea A, Rodriguez-Fernandez P, Alfaro S, Gracia B, Lucía A, Usón L, Gomez AC, Mendoza G, Lacoma A, Dominguez J, Prat C, Sebastian V, Ainsa JA, Arruebo M.

Nanomedicine (Lond). 2019 Mar;14(6):707-726. doi: 10.2217/nnm-2018-0258. Epub 2019 Feb 8.

PMID:
30734643
5.

Serum levels of hyaluronic acid are associated with COPD severity and predict survival.

Papakonstantinou E, Bonovolias I, Roth M, Tamm M, Schumann D, Baty F, Louis R, Milenkovic B, Boersma W, Stieltjes B, Kostikas K, Blasi F, Aerts JG, Rohde GGU, Lacoma A, Torres A, Welte T, Stolz D.

Eur Respir J. 2019 Mar 7;53(3). pii: 1801183. doi: 10.1183/13993003.01183-2018. Print 2019 Mar.

6.

Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.

Latorre I, Fernández-Sanmartín MA, Muriel-Moreno B, Villar-Hernández R, Vila S, Souza-Galvão ML, Stojanovic Z, Jiménez-Fuentes MÁ, Centeno C, Ruiz-Manzano J, Millet JP, Molina-Pinargote I, González-Díaz YD, Lacoma A, Luque-Chacón L, Sabriá J, Prat C, Domínguez J.

Front Immunol. 2019 Jan 9;9:3094. doi: 10.3389/fimmu.2018.03094. eCollection 2018.

7.

Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin.

Bruguera-Àvila N, Garcia-Olive I, Marin A, Prat C, Lacoma A, Gil M, Abad Capa J.

Respiration. 2019;97(6):501-507. doi: 10.1159/000495069. Epub 2019 Jan 3.

PMID:
30605912
8.

Persistent Isolation of Staphylococcus aureus in Mechanically-ventilated Patients: Impact of Host-Pathogen Factors on Outcome.

Lacoma A, Gomes-Fernandes M, Mesalles E, Arméstar F, Prat C.

Arch Bronconeumol. 2019 Mar;55(3):158-160. doi: 10.1016/j.arbres.2018.05.010. Epub 2018 Jul 3. English, Spanish. No abstract available.

PMID:
29980308
9.

Characterization of clinically relevant model bacterial strains of Pseudomonas aeruginosa for anti-biofilm testing of materials.

Rzhepishevska O, Limanska N, Galkin M, Lacoma A, Lundquist M, Sokol D, Hakobyan S, Sjöstedt A, Prat C, Ramstedt M.

Acta Biomater. 2018 Aug;76:99-107. doi: 10.1016/j.actbio.2018.06.019. Epub 2018 Jun 12.

PMID:
29902594
10.

IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes.

Egli A, Mandal J, Schumann DM, Roth M, Thomas B, Lorne Tyrrell D, Blasi F, Kostikas K, Boersma W, Milenkovic B, Lacoma A, Rentsch K, Rohde GGU, Louis R, Aerts JG, Welte T, Torres A, Tamm M, Stolz D.

BMC Pulm Med. 2018 Mar 21;18(1):51. doi: 10.1186/s12890-018-0616-6.

11.

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD.

Mandal J, Roth M, Papakonstantinou E, Sun Q, Costa L, Boeck L, Scherr A, Rakic J, Louis R, Milenkovic B, Boersma W, Kostikas K, Blasi F, Aerts J, Rohde G, Lacoma A, Torres A, Welte T, Tamm M, Stolz D.

Pulm Pharmacol Ther. 2018 Feb;48:111-116. doi: 10.1016/j.pupt.2017.10.011. Epub 2017 Oct 21.

12.

Investigating intracellular persistence of Staphylococcus aureus within a murine alveolar macrophage cell line.

Lacoma A, Cano V, Moranta D, Regueiro V, Domínguez-Villanueva D, Laabei M, González-Nicolau M, Ausina V, Prat C, Bengoechea JA.

Virulence. 2017 Nov 17;8(8):1761-1775. doi: 10.1080/21505594.2017.1361089. Epub 2017 Sep 12.

13.

PyroTyping, a novel pyrosequencing-based assay for Mycobacterium tuberculosis genotyping.

Molina-Moya B, Lacoma A, García-Sierra N, Blanco S, Haba L, Samper S, Ruiz-Manzano J, Prat C, Arnold C, Domínguez J.

Sci Rep. 2017 Jul 28;7(1):6777. doi: 10.1038/s41598-017-06760-5.

14.

Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.

Villar-Hernández R, Latorre I, Mínguez S, Díaz J, García-García E, Muriel-Moreno B, Lacoma A, Prat C, Olivé A, Ruhwald M, Mateo L, Domínguez J.

J Infect. 2017 Oct;75(4):315-325. doi: 10.1016/j.jinf.2017.07.004. Epub 2017 Jul 25.

PMID:
28751171
15.

Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT.

Molina-Moya B, Gomgnimbou MK, Lafoz C, Lacoma A, Prat C, Refrégier G, Samper S, Dominguez J, Sola C.

Am J Trop Med Hyg. 2017 Sep;97(3):806-809. doi: 10.4269/ajtmh.16-0782. Epub 2017 Jul 19.

16.

Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections.

Gomes-Fernandes M, Laabei M, Pagan N, Hidalgo J, Molinos S, Villar Hernandez R, Domínguez-Villanueva D, Jenkins ATA, Lacoma A, Prat C.

PLoS One. 2017 Apr 14;12(4):e0175552. doi: 10.1371/journal.pone.0175552. eCollection 2017.

17.

Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens.

Martínez I, Oliveros JC, Cuesta I, de la Barrera J, Ausina V, Casals C, de Lorenzo A, García E, García-Fojeda B, Garmendia J, González-Nicolau M, Lacoma A, Menéndez M, Moranta D, Nieto A, Ortín J, Pérez-González A, Prat C, Ramos-Sevillano E, Regueiro V, Rodriguez-Frandsen A, Solís D, Yuste J, Bengoechea JA, Melero JA.

Front Microbiol. 2017 Mar 1;8:276. doi: 10.3389/fmicb.2017.00276. eCollection 2017.

18.

Bacteria in the respiratory tract-how to treat? Or do not treat?

Prat C, Lacoma A.

Int J Infect Dis. 2016 Oct;51:113-122. doi: 10.1016/j.ijid.2016.09.005. Review.

19.

Correction for Molina-Moya et al., Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Molina-Moya B, Kazdaglis G, Lacoma A, Prat C, Gómez A, Villar-Hernández R, García-García E, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Domínguez J.

J Clin Microbiol. 2016 Aug;54(8):2211. doi: 10.1128/JCM.01181-16. No abstract available.

20.

Prognostic assessment in COPD without lung function: the B-AE-D indices.

Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D.

Eur Respir J. 2016 Jun;47(6):1635-44. doi: 10.1183/13993003.01485-2015. Epub 2016 Apr 21.

21.

Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.

Baumeler L, Papakonstantinou E, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Kostikas K, Blasi F, Boersma W, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D.

Respirology. 2016 Jul;21(5):883-90. doi: 10.1111/resp.12758. Epub 2016 Mar 11.

22.

Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis.

Molina-Moya B, Kazdaglis G, Lacoma A, Prat C, Gómez A, Villar-Hernández R, García-García E, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Domínguez J.

J Clin Microbiol. 2016 Apr;54(4):1160-3. doi: 10.1128/JCM.03341-15. Epub 2016 Feb 10. Erratum in: J Clin Microbiol. 2016 Aug;54(8):2211.

23.

Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.

Mandal J, Malla B, Steffensen R, Costa L, Egli A, Trendelenburg M, Blasi F, Kostikas K, Welte T, Torres A, Louis R, Boersma W, Milenkovic B, Aerts J, Rohde GG, Lacoma A, Rentsch K, Roth M, Tamm M, Stolz D.

Respir Res. 2015 Dec 18;16:150. doi: 10.1186/s12931-015-0306-3.

24.

Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.

Lacoma A, Molina-Moya B, Prat C, Pimkina E, Diaz J, Dudnyk A, García-Sierra N, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Ausina V, Dominguez J.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):263-9. doi: 10.1016/j.diagmicrobio.2015.07.004. Epub 2015 Jul 11.

PMID:
26256417
25.

Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance.

Molina-Moya B, Lacoma A, Prat C, Pimkina E, Diaz J, García-Sierra N, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Ausina V, Dominguez J.

J Infect. 2015 Aug;71(2):220-30. doi: 10.1016/j.jinf.2015.03.011. Epub 2015 Apr 30.

PMID:
25936742
26.

Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis.

Serra-Vidal MM, Latorre I, Franken KL, Díaz J, de Souza-Galvão ML, Casas I, Maldonado J, Milà C, Solsona J, Jimenez-Fuentes MÁ, Altet N, Lacoma A, Ruiz-Manzano J, Ausina V, Prat C, Ottenhoff TH, Domínguez J.

Front Microbiol. 2014 Oct 8;5:517. doi: 10.3389/fmicb.2014.00517. eCollection 2014.

27.

AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples.

Molina-Moya B, Lacoma A, Prat C, Diaz J, Dudnyk A, Haba L, Maldonado J, Samper S, Ruiz-Manzano J, Ausina V, Dominguez J.

J Infect. 2015 Apr;70(4):400-8. doi: 10.1016/j.jinf.2014.09.010. Epub 2014 Oct 12.

PMID:
25305498
28.

Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection.

Díez N, Giner E, Latorre I, Lacoma A, Roig FJ, Mialdea I, Díaz J, Serra-Vidal M, Escribano A, Domínguez J.

Pediatr Infect Dis J. 2015 Feb;34(2):219-21. doi: 10.1097/INF.0000000000000514.

PMID:
25144799
29.

Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.

Stolz D, Boersma W, Blasi F, Louis R, Milenkovic B, Kostikas K, Aerts JG, Rohde G, Lacoma A, Rakic J, Boeck L, Castellotti P, Scherr A, Marin A, Hertel S, Giersdorf S, Torres A, Welte T, Tamm M.

Chest. 2014 Aug;146(2):328-338. doi: 10.1378/chest.13-1967.

PMID:
24722847
30.

Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores.

Lacoma A, Bas A, Tudela P, Giménez M, Mòdol JM, Pérez M, Ausina V, Dominguez J, Prat-Aymerich C.

Enferm Infecc Microbiol Clin. 2014 Mar;32(3):140-6. doi: 10.1016/j.eimc.2013.07.006. Epub 2013 Sep 19.

PMID:
24054971
31.

Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index.

Stolz D, Kostikas K, Blasi F, Boersma W, Milenkovic B, Lacoma A, Louis R, Aerts JG, Welte T, Torres A, Rohde GG, Boeck L, Rakic J, Scherr A, Hertel S, Giersdorf S, Tamm M.

Eur Respir J. 2014 Feb;43(2):397-408. doi: 10.1183/09031936.00058713. Epub 2013 Jun 21. Erratum in: Eur Respir J. 2014 Dec;44(6):1718.

32.

Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit.

Ferrè C, de Guzmao BM, Morgades M, Lacoma A, Marcos P, Jiménez-Lorenzo MJ, Xicoy B, Misis M, Prat C, Bordejé ML, Domínguez J, Feliu E, Ribera JM.

Leuk Lymphoma. 2012 Oct;53(10):1966-70. doi: 10.3109/10428194.2012.543715.

PMID:
22938139
33.

Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Mínguez S, Latorre I, Mateo L, Lacoma A, Diaz J, Olivé A, Domínguez J.

Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21.

PMID:
22271230
34.

[Relationship between procalcitonin serum levels and complications and outcome of patients with hematological malignancy admitted to Intensive Care Unit].

Ferrà C, Lacoma A, García O, Marcos P, Domínguez J, Ribera JM.

Med Clin (Barc). 2012 Apr 14;138(9):385-8. doi: 10.1016/j.medcli.2011.09.036. Epub 2012 Jan 16. Spanish.

PMID:
22257606
35.

GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.

Lacoma A, García-Sierra N, Prat C, Maldonado J, Ruiz-Manzano J, Haba L, Gavin P, Samper S, Ausina V, Domínguez J.

J Clin Microbiol. 2012 Jan;50(1):30-6. doi: 10.1128/JCM.05274-11. Epub 2011 Nov 9.

36.

[Biomarkers and suspicion of infection in emergency departments].

Tudela P, Prat C, Lacoma A, Mòdol JM.

Med Clin (Barc). 2012 Jun 2;139(1):33-7. doi: 10.1016/j.medcli.2011.09.018. Epub 2011 Nov 8. Spanish. No abstract available.

PMID:
22075231
37.

Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy.

Latorre I, Altet N, de Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Pérez M, Ausina V, Domínguez J.

Scand J Infect Dis. 2012 Mar;44(3):161-7. doi: 10.3109/00365548.2011.611167. Epub 2011 Sep 19.

PMID:
21923628
38.

Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia.

Lacoma A, Rodríguez N, Prat C, Ruiz-Manzano J, Andreo F, Ramírez A, Bas A, Pérez M, Ausina V, Domínguez J.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):825-33. doi: 10.1007/s10096-011-1381-0. Epub 2011 Aug 26.

PMID:
21870054
39.

Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens.

García-Sierra N, Lacoma A, Prat C, Haba L, Maldonado J, Ruiz-Manzano J, Gavin P, Samper S, Ausina V, Domínguez J.

J Clin Microbiol. 2011 Oct;49(10):3683-6. doi: 10.1128/JCM.01239-11. Epub 2011 Aug 3.

40.

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.

Lacoma A, Prat C, Andreo F, Lores L, Ruiz-Manzano J, Ausina V, Domínguez J.

Int J Chron Obstruct Pulmon Dis. 2011;6:157-69. doi: 10.2147/COPD.S16070. Epub 2011 Feb 28.

41.

IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.

Latorre I, Martínez-Lacasa X, Font R, Lacoma A, Puig J, Tural C, Lite J, Prat C, Cuchi E, Ausina V, Domínguez J.

BMC Infect Dis. 2010 Dec 10;10:348. doi: 10.1186/1471-2334-10-348.

42.

Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease.

Lacoma A, Prat C, Andreo F, Lores L, Latorre I, Pérez M, Ruiz-Manzano J, Ausina V, Dominguez J.

Clin Chim Acta. 2011 Feb 20;412(5-6):470-5. doi: 10.1016/j.cca.2010.11.032. Epub 2010 Dec 4.

PMID:
21138742
43.

[Prediction of bacteremia in patients with suspicion of infection in emergency room].

Tudela P, Lacoma A, Prat C, Mòdol JM, Giménez M, Barallat J, Tor J.

Med Clin (Barc). 2010 Nov 20;135(15):685-90. doi: 10.1016/j.medcli.2010.04.009. Epub 2010 Jun 16. Spanish.

PMID:
20557905
44.

[Importance of biomarkers in diagnosis, prognosis and new therapies in infectious diseases].

Lacoma A, Prat C, Ausina V.

Enferm Infecc Microbiol Clin. 2010 May;28(5):263-5. doi: 10.1016/j.eimc.2010.02.004. Epub 2010 Apr 8. Spanish. No abstract available.

PMID:
20381208
45.

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis.

Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Altet N, Ausina V, Domínguez J.

Eur Respir J. 2010 Feb;35(2):338-42. doi: 10.1183/09031936.00196608.

46.

Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children.

Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Fuenzalida L, Altet N, Ausina V, Domínguez J.

Diagn Microbiol Infect Dis. 2009 Nov;65(3):236-46. doi: 10.1016/j.diagmicrobio.2009.07.015.

PMID:
19822269
47.

Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.

Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, García-Olivé I, Lacoma A, Ausina V, Domínguez J.

PLoS One. 2009 Aug 24;4(8):e6686. doi: 10.1371/journal.pone.0006686.

48.

Biomarkers in the management of COPD.

Lacoma A, Prat C, Andreo F, Domínguez J.

Eur Respir Rev. 2009 Jun;18(112):96-104. doi: 10.1183/09059180.00000609. Review.

49.

Evaluation of a latex agglutination test (PYLOGEN) for the detection of Helicobacter pylori in stool specimens.

Blanco S, Forné M, Lacoma A, Prat C, Cuesta MA, Fuenzalida L, Viver JM, Domínguez J.

Diagn Microbiol Infect Dis. 2009 Apr;63(4):349-53. doi: 10.1016/j.diagmicrobio.2008.12.006. Epub 2009 Feb 18.

PMID:
19232854
50.

[Utility of molecular biology in the microbiological diagnosis of mycobacterial infections].

Domínguez J, Blanco S, Lacoma A, García-Sierra N, Prat C, Ausina V.

Enferm Infecc Microbiol Clin. 2008 Jul;26 Suppl 9:33-41. Review. Spanish.

PMID:
19195445

Supplemental Content

Loading ...
Support Center